Human Tetherin Exerts Strong Selection Pressure on the HIV-1 Group N Vpu Protein

PLoS Pathogens

Volumn 8, Issue 12, 2012, Pages

  Sauter, Daniel ^a   Unterweger, Daniel ^a   Vogl, Michael ^a   Usmani, Shariq M ^a   Heigele, Anke ^a   Kluge, Silvia F ^a   Hermkes, Elisabeth ^a   Moll, Markus ^b   Barker, Edward ^c   Peeters, Martine ^d   Learn, Gerald H ^e   Bibollet Ruche, Frederic ^e   Fritz, Joëlle V ^f   Fackler, Oliver T ^f   Hahn, Beatrice H ^e   Kirchhoff, Frank ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITÉ DE MONTPELLIER   (France)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; TETHERIN; UNCLASSIFIED DRUG; VPU PROTEIN;

AMINO ACID SEQUENCE; ANTIBIOSIS; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HOST SELECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SEQUENCE ANALYSIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIGENS, CD; BINDING SITES; BLOTTING, WESTERN; CELLS, CULTURED; FLOW CYTOMETRY; GPI-LINKED PROTEINS; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN INTERACTION DOMAINS AND MOTIFS; SELECTION, GENETIC; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS RELEASE;

HUMAN IMMUNODEFICIENCY VIRUS 1; PAN;

EID: 84872017729     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003093     Document Type: Article

References (60)

1. Sharp PM, Hahn BH, (2010) The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci 365: 2487-2494.
2. Bodelle P, Vallari A, Coffey R, McArthur CP, Beyeme M, et al. (2004) Identification and genomic sequence of an HIV type 1 group N isolate from Cameroon. AIDS Res. Hum. Retroviruses 20: 902-908.
3. Delaugerre C, De Oliveira F, Lascoux-Combe C, Plantier JC, Simon F, (2011) HIV-1 group N: travelling beyond Cameroon. Lancet 378: 9806.
4. Roques P, Robertson DL, Souquière S, Apetrei C, Nerrienet E, et al. (2004) Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N. AIDS 18: 1371-1381.
5. Simon F, Mauclère P, Roques P, Loussert-Ajaka I, Müller-Trutwin MC, et al. (1998) Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 4: 1032-1037.
6. Vallari A, Bodelle P, Ngansop C, Makamche F, Ndembi N, et al. (2010) Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low. AIDS Res Hum Retroviruses 26: 109-115.
7. Yamaguchi J, McArthur CP, Vallari A, Coffey R, Bodelle P, et al. (2006) HIV-1 Group N: evidence of ongoing transmission in Cameroon. AIDS Res Hum Retroviruses 22: 453-457.
8. Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, et al. (2009) A new human immunodeficiency virus derived from gorillas. Nature Medicine 15: 871-872.
9. Vallari A, Holzmayer V, Harris B, Yamaguchi J, Ngansop C, et al. (2011) Confirmation of Putative HIV-1 Group P in Cameroon. Journal of Virology 85: 1403-1407.
10. Malim MH, Emerman M, (2008) HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3: 388-398.
11. Kirchhoff F, (2010) Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8: 55-67.
12. Sauter D, Specht A, Kirchhoff F, (2010) Tetherin: holding on and letting go. Cell 141: 392-398.
13. Hinz A, Miguet N, Natrajan G, Usami Y, Yamanaka H, et al. (2010) Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain. Cell Host Microbe 7: 314-323.
14. Kupzig S, Korolchuk V, Rollason R, Sugden A, Wilde A, et al. (2003) Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4: 694-709.
15. Neil SJ, Zang T, Bieniasz PD, (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
16. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, et al. (2009) Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139: 499-511.
17. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, et al. (2008) The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3: 245-252.
18. Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, et al. (2009) Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLOS Pathog 5: 1000429.
19. Sauter D, Schindler M, Specht A, Landford WN, Münch J, et al. (2009) Tetherin-driven evolution of Vpu and Nef function and the emergence of pandemic and non-pandemic HIV-1 strains. Cell Host Microbe 6: 409-421.
20. Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, et al. (2009) Nef Proteins from Simian Immunodeficiency Viruses Are Tetherin Antagonists. Cell Host Microbe 6: 54-67.
21. Sauter D, Hué S, Petit SJ, Plantier JC, Towers GJ, et al. (2011) HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef. Retrovirology 8: 103.
22. Yang SJ, Lopez LA, Exline CM, Haworth KG, Cannon PM, et al. (2011) Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology 8: 78.
23. Yang SJ, Lopez LA, Hauser H, Exline CM, Haworth KG, et al. (2010) Anti-tetherin activities in Vpu-expressing primate lentiviruses. Retrovirology 7: 13.
24. Moll M, Andersson SK, Smed-Sörensen A, Sandberg JK, (2010) Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 116: 1876-1884.
25. Shah AH, Sowrirajan B, Davis ZB, Ward JP, Campbell EM, et al. (2010) Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe 8: 397-409.
26. Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, et al. (2006) Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313: 523-526.
27. Gupta RK, Hué S, Schaller T, Verschoor E, Pillay D, et al. (2009) Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog 5: e1000443.
28. McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, et al. (2009) Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog 5: e1000300.
29. Petit SJ, Blondeau C, Towers GJ, (2011) Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin. J Gen Virol 92: 2937-2948.
30. Vigan R, Neil SJ, (2010) Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. J Virol 84: 12958-12970.
31. Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Früh K, (2009) Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J Virol 83: 7931-7947.
32. Dubé M, Roy BB, Guiot-Guillain P, Binette J, Mercier J, (2010) Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog 6: e1000856.
33. Kobayashi T, Ode H, Yoshida T, Sato K, Gee P, et al. (2011) Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility. J Virol 85: 932-945.
34. Lim ES, Malik HS, Emerman M, (2010) Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses. J Virol 84: 7124-7134.
35. Andrew A, Strebel K, (2010) HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms. Mol Aspects Med 31: 407-417.
36. Evans DT, Serra-Moreno R, Singh RK, Guatelli JC, (2010) BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol 18: 388-396.
37. Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, et al. (2009) Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog 5: 1000450.
38. Schindler M, Rajan D, Banning C, Wimmer P, Koppensteiner H, et al. (2010) Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue. Retrovirology 7: 1.
39. Tervo HM, Homann S, Ambiel I, Fritz JV, Fackler OT, et al. (2011) β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release. Retrovirology 8: 9.
40. Villalobos V, Naik S, Bruinsma M, Dothager RS, Pan MH, et al. (2010) Dual-color click beetle luciferase heteroprotein fragment complementation assays. Chem Biol 17: 1018-1029.
41. Margottin F, Bour SP, Durand H, Selig L, Benichou S, et al. (1998) A novel human WD protein, h-TrCP, that interacts with HIV-1 Vpu, connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell 1: 565-574.
42. Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, et al. (2009) HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog 5: e1000574.
43. Kueck T, Neil SJ, (2012) A Cytoplasmic Tail Determinant in HIV-1 Vpu Mediates Targeting of Tetherin for Endosomal Degradation and Counteracts Interferon-Induced Restriction. PLoS Pathog 8: e1002609.
44. Schmidt S, Fritz JV, Bitzegeio J, Fackler OT, Keppler OT, (2011) HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction. MBio 2: e00036-11.
45. Gupta RK, Towers GJ, (2009) A tail of Tetherin: how pandemic HIV-1 conquered the world. Cell Host Microbe 6: 393-395.
46. Doehle BP, Chang K, Fleming L, McNevin J, Hladik F, et al. (2012) Vpu-Deficient HIV Strains Stimulate Innate Immune Signaling Responses in Target Cells. J Virol 86: 8499-8506.
47. Doehle BP, Chang K, Rustagi A, McNevin J, McElrath MJ, et al. (2012) Vpu Mediates Depletion of Interferon Regulatory Factor 3 during HIV Infection by a Lysosome-Dependent Mechanism. J Virol 86: 8367-8374.
48. Yamaguchi J, Coffey R, Vallari A, Ngansop C, Mbanya D, et al. (2006) Identification of HIV type 1 group N infections in a husband and wife in Cameroon: viral genome sequences provide evidence for horizontal transmission. AIDS Res Hum Retroviruses 22: 83-92.
49. Vigan R, Neil SJ, (2011) Separable determinants of subcellular localization and interaction account for the inability of group O HIV-1 Vpu to counteract tetherin. J Virol 85: 9737-9748.
50. Tomescu C, Abdulhaqq S, Montaner LJ, (2011) Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). Clin Exp Immunol 164: 158-169.
51. Münch J, Rajan D, Schindler M, Specht A, Rücker E, et al. (2007) Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. J Virol 81: 13852-13864.
52. Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O'Brien WA, et al. (2000) Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol 74: 8358-8367.
53. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D, (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72: 2855-2864.
54. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46: 1896-1905.
55. Schindler M, Münch J, Kutsch O, Li H, Santiago ML, et al. (2006) Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125: 1055-1067.
56. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
57. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, et al. (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73: 152-160.
58. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, et al. (2010) New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59: 307-321.
59. Jones DT, Taylor WR, Thornton JM, (1992) A new approach to protein fold recognition. Nature 358: 86-89.
60. Abascal F, Zardoya R, Posada D, (2005) ProtTest: selection of best-fit models of protein evolution. Bioinformatics 21: 2104-2105.